Recent Finacing
Recent Raise
Cibiem develops a proprietary minimally invasive catheter-based Carotid Body Modulation (CBM) therapy for sympathetic nervous system–mediated diseases, conducting first-in-man clinical trials for hypertension, heart failure, diabetes and renal failure.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors